2,4-dimethoxybenzaldehyde

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Mardaryev, Andrei N: 1 article (01/2020)

1.	Papilloma (Papillomatosis) 01/01/2020 - "This protocol allows researchers to reliably induce benign papilloma development and their conversion to squamous cell carcinoma in the skin of susceptible mouse strains in response to a single dose of carcinogen 2,4-dimethoxybenzaldehyde (DMBA) and repetitive applications of tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA)."
2.	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/01/2020 - "This protocol allows researchers to reliably induce benign papilloma development and their conversion to squamous cell carcinoma in the skin of susceptible mouse strains in response to a single dose of carcinogen 2,4-dimethoxybenzaldehyde (DMBA) and repetitive applications of tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA)."

1.	Carcinogens